AfricaRise: Novartis in Africa

Primary tabs

AfricaRise: Novartis in Africa

Focusing on patients, fueling growth
At a glance: Novartis in Africa

At a glance: Novartis in Africa

tweet me:
Novartis wants to triple access to its medicines in #Africa by 2018. Find out how: http://bit.ly/1EhfOAU
Friday, February 13, 2015 - 5:00pm

CONTENT: Article

Novartis has a long-standing relationship and commitment to Africa, with decades of experience on the ground. Today, we are the third-largest multinational healthcare company on the continent, and we aim to become the leading healthcare company by tripling access to our medicines by 2018.

About Novartis
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and over-the-counter products. Novartis is the only global company with leading positions in these areas. In 2014, the Group achieved net sales of USD 58 billion, while R&D throughout the Group amounted to approximately USD 9.9 billion (USD 9.6 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 130,000 full-time-equivalent associates. Novartis products are available in more than 180 countries around the world.

About Corporate Responsibility at Novartis
We aim to improve global health. Through our business, we make an important contribution to society: We discover and develop innovative medicines and vaccines. Novartis collaborates with others to help address some of the world’s greatest health challenges. We focus our corporate responsibility work on two areas that underscore our mission of caring and curing.

Expanding access to healthcare.We work to control and eliminate diseases such as malaria and leprosy, pioneer new business approaches and healthcare delivery models to reach underserved patients, and find new treatments and adaptive solutions to improve health in developing countries. In 2014, these efforts reached more than 70 million people.

Doing business responsibly. This is a core part of Novartis. We care for our associates, strive to positively contribute to the communities where we live and work, and protect the environment. We conduct business ethically, maintaining a Code of Conduct and governance system to ensure our associates uphold our values.

Keywords: Health & Healthcare | Alcon | Novartis | Pharmaceuticals | Sandoz | Socially Responsible Investing | Sustainable Finance & Socially Responsible Investment | africa | eye care | generic medicines | noncommunicable diseases (NCDs)

CONTENT: Article

parse.ly